High-Performance Glycoanalysis Solutions for Biopharma and Biotech Industries and for Clinical Applications

Transforming Glycosciences in the US


In response to a request from the National Institutes of Health (NIH), the Food and Drug Administration (FDA), the US Department of Energy (DoE), and the National Science Foundation (NSF), the National Research Council convened a committee to assess the importance and impact of glycoscience, explore the landscape of current research, and identify the challenges that will need to be addressed to enable the field to move forward.

The committee was charged to 'articulate a unified vision for the field on glycoscience and glycomics' and to 'develop a roadmap with concrete research goals to significantly advance [the field]'.

The committee's consensus findings, conclusions, and recommendations in addressing this charge are summarised in this document.

Download to find out more.

Available Downloads